| 臺大學術典藏 |
2021-04-22T06:56:45Z |
Successful colonoscopic drainage of appendiceal pus in acute appendicitis
|
Liu C.-H.; Tsai F.-C.; Hsu S.-J.; PEI-MING YANG |
| 臺大學術典藏 |
2021-04-22T06:56:43Z |
Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis
|
Liu C.-H.; Hsu S.-J.; Liang C.-C.; Tsai F.-C.; Lin J.-W.; Liu C.-J.; PEI-MING YANG; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-04-22T06:56:42Z |
Hepatocellular carcinoma with duodenal invasion and metastasis
|
Liang J.-D.; Chen C.-H.; Hsu S.-J.; Sheu J.-C.; PEI-MING YANG; Lee H.-S.; Lee C.-Z.; Huang G.-T. |
| 臺大學術典藏 |
2021-03-18T02:03:09Z |
Bleeding jejunal lymphangioma diagnosed by double-balloon enteroscopy.
|
Hsu S.J.; Chang Y.T.; Chang M.C.; Yu S.C.; Lee J.C.; CHIA-TUNG SHUN; Wong J.M. |
| 臺大學術典藏 |
2021-03-18T02:02:50Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.;Chen C.-C.;Chang C.-Y.;Chen M.-J.;Fang Y.-J.;Lee J.-Y.;Chen C.-C.;Hsu S.-J.;Hsu Y.-C.;Tseng C.-H.;Tseng P.-H.;Chang L.;Chang W.-H.;Wang H.-P.;Chia-Tung Shun;Wu J.-Y.;Lee Y.-C.;Lin J.-T.;Wu M.-S.;Lin C.-H.;Chow L.-P.;Cheng T.-Y.;Wu C.-Y.;Lee Ching-Tai C.-T, Wang W.-L.;Tai C.-M.;Wang Y.-C.;Wang C.-H.;Kuo S.-H.;Wu C.-Y.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; CHIA-TUNG SHUN; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-03-18T02:02:50Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.;Chen C.-C.;Chen M.-J.;Chen C.-C.;Chang C.-Y.;Fang Y.-J.;Lee J.-Y.;Hsu S.-J.;Luo J.-C.;Chang W.-H.;Hsu Y.-C.;Tseng C.-H.;Tseng P.-H.;Wang H.-P.;Yang U.-C.;Chia-Tung Shun;Lin J.-T.;Lee Y.-C.;Wu M.-S.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; CHIA-TUNG SHUN; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-10T07:09:13Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; TSU-YAO CHENG; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:32Z |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
TUNG-HUNG SU; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; Chen C.-L.; Kao J.-H.; the C-TEAM study group; the Taiwan Liver Diseases Consortium |
| 臺大學術典藏 |
2021-03-09T01:47:31Z |
High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments
|
Nien H.-C.; Hsu S.-J.; TUNG-HUNG SU; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; Kao J.-H.; Yang W.-S. |
| 臺大學術典藏 |
2021-03-05T08:19:42Z |
Trichuris suis therapy for ulcerative colitis: Nonresponsive patients may need anti-helminth therapy [2] (multiple letters)
|
Hsu S.-J.; PING-HUEI TSENG; Chen P.-J.; Summers R.W.; Elliott D.E.; Weinstock J.V. |
| 臺大學術典藏 |
2021-03-05T08:19:38Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; PING-HUEI TSENG; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-05T08:19:37Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-03-05T08:19:37Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-05T06:07:32Z |
Bleeding jejunal lymphangioma diagnosed by double-balloon enteroscopy.
|
Hsu S.J.; Chang Y.T.; MING-CHU CHANG; Yu S.C.; Lee J.C.; Shun C.T.; Wong J.M. |
| 臺大學術典藏 |
2021-02-18T08:38:12Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
CHIEN-CHUAN CHEN; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-18T08:38:11Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chieh-Chang Chen; Chen M.-J.; CHIEN-CHUAN CHEN; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-02-18T08:38:10Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chieh-Chang Chen; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEN-CHUAN CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-18T08:01:16Z |
Hepatocellular carcinoma with duodenal invasion and metastasis
|
JA-DER LIANG; Chen C.-H.; Hsu S.-J.; Sheu J.-C.; Yang P.-M.; Lee H.-S.; Lee C.-Z.; Huang G.-T. |
| 臺大學術典藏 |
2021-02-18T08:01:13Z |
Safety of perfluorobutane (Sonazoid) in characterizing focal liver lesions
|
Chou Y.-H.; JA-DER LIANG; Wang S.-Y.; Hsu S.-J.; Hu J.-T.; Yang S.-S.; Wang H.-K.; Lee T.-Y.; Tiu C.-M. |
| 臺大學術典藏 |
2021-02-02T07:50:58Z |
Hepatocellular carcinoma with duodenal invasion and metastasis
|
Liang J.-D.; Chen C.-H.; Hsu S.-J.; Sheu J.-C.; Yang P.-M.; Lee H.-S.; Lee, Cha-Ze; Huang G.-T. |
| 臺大學術典藏 |
2021-02-02T06:40:58Z |
Hepatocellular carcinoma with duodenal invasion and metastasis
|
Liang J.-D.; Chen C.-H.; Hsu S.-J.; Sheu J.-C.; Yang P.-M.; Lee, Hsuan-Shu; Lee C.-Z.; Huang G.-T.; Liang J.-D.; Chen C.-H.; Hsu S.-J.; Sheu J.-C.; Yang P.-M.; Lee, Hsuan-Shu; Lee C.-Z.; Huang G.-T. |
| 臺大學術典藏 |
2021-02-02T05:45:30Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.;Chen C.-C.;Chen M.-J.;Chen C.-C.;Chang C.-Y.;Fang Y.-J.;Lee J.-Y.;Hsu S.-J.;Luo J.-C.;Chang W.-H.;Hsu Y.-C.;Tseng C.-H.;Tseng P.-H.;Wang H.-P.;Yang U.-C.;Shun C.-T.;Lin J.-T.;Yi-Chia Lee;Wu M.-S.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; YI-CHIA LEE; Wu M.-S. |
| 臺大學術典藏 |
2021-02-02T05:45:29Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.;Chen C.-C.;Chang C.-Y.;Chen M.-J.;Fang Y.-J.;Lee J.-Y.;Chen C.-C.;Hsu S.-J.;Hsu Y.-C.;Tseng C.-H.;Tseng P.-H.;Chang L.;Chang W.-H.;Wang H.-P.;Shun C.-T.;Wu J.-Y.;Yi-Chia Lee;Lin J.-T.;Wu M.-S.;Lin C.-H.;Chow L.-P.;Cheng T.-Y.;Wu C.-Y.;Lee Ching-Tai C.-T, Wang W.-L.;Tai C.-M.;Wang Y.-C.;Wang C.-H.;Kuo S.-H.;Wu C.-Y.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; YI-CHIA LEE; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:40Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; MING-SHIANG WU; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:37Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:35Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-01-15T03:46:56Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; HSIU-PO WANG; Lin J.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:54Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; HSIU-PO WANG; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:53Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; HSIU-PO WANG; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 國立成功大學 |
2021 |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
Hong, C.-M.;Lin, Y.-Y.;Liu, C.-J.;Lai, Y.-Y.;Yeh, S.-H.;Yang, H.-C.;Kao, J.-H.;Hsu, S.-J.;Huang, Y.-H.;Yang, S.-S.;Kuo, H.-T.;Cheng, P.-N.;Yu, M.-L.;Chen, P.-J. |
| 臺大學術典藏 |
2020-11-27T03:28:40Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chien-Chuan Chen; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-27T03:28:40Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chen M.-J.; Chien-Chuan Chen; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:36Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; CHIEH-CHANG CHEN; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:49Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; MING-SHIANG WU; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:47Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
MING-SHIANG WU; Lee Y.-C.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:45Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L. |
| 臺大學術典藏 |
2020-09-22T07:39:52Z |
In vivo three-dimensional intervertebral kinematics of the subaxial cervical spine during seated axial rotation and lateral bending via a fluoroscopy-to-CT registration approach
|
Lin C.-C.; Lu T.-W.; Wang T.-M.; CHAO-YU HSU; Hsu S.-J.; Shih T.-F. |
| 臺大學術典藏 |
2020-08-06T07:51:50Z |
In vivo three-dimensional intervertebral kinematics of the subaxial cervical spine during seated axial rotation and lateral bending via a fluoroscopy-to-CT registration approach
|
TIFFANY TING-FANG SHIH; Hsu S.-J.; Lin C.-C.; Lu T.-W.; Wang T.-M.; Hsu C.-Y. |
| 臺大學術典藏 |
2020-07-05T03:14:28Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Wu M.-S.; Lee Y.-C.; Lin J.-T.; CHIA-TUNG SHUN; Yang U.-C.; Wang H.-P.; Lee J.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Fang Y.-J.; Chang C.-Y.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C. |
| 臺大學術典藏 |
2020-03-07T06:52:18Z |
Bleeding jejunal lymphangioma diagnosed by double-balloon enteroscopy.
|
Hsu S.J.; Chang Y.T.; Chang M.C.; Yu S.C.; JEN-CHIEH LEE; Shun C.T.; Wong J.M. |
| 臺大學術典藏 |
2020-03-05T06:39:02Z |
Bleeding jejunal lymphangioma diagnosed by double-balloon enteroscopy.
|
Hsu S.J.; Chang Y.T.; Chang M.C.; Yu S.C.; JEN-CHIEH LEE; Shun C.T.; Wong J.M. |
| 臺大學術典藏 |
2020-03-04T09:03:25Z |
Magnetocardiography of animals in magnetically shielded environment with active compensation
|
Horng H.E.;Liao S.H.;Hsu S.J.;Yang H.C.;Wu J.Y.;Chen C.C.;Wu C.H.;Chau-Chung Wu; Horng H.E.; Liao S.H.; Hsu S.J.; Yang H.C.; Wu J.Y.; Chen C.C.; Wu C.H.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-02-26T01:33:58Z |
The development of wireless sensor network for ECG monitoring
|
Fu-Shan JawLin, J.-L.;Liu, H.-C.;Tai, Y.-T.;Wu, H.-H.;Hsu, S.-J.;Jaw, F.-S.;Chen, Y.-Y.; Lin, J.-L.; Liu, H.-C.; Tai, Y.-T.; Wu, H.-H.; Hsu, S.-J.; Jaw, F.-S.; Chen, Y.-Y.; FU-SHAN JAW |
| 臺大學術典藏 |
2020-02-07T07:26:53Z |
Effects of monosodium glutamate loading upon plasma free amino acids and ammonia levels in Chinese male adults
|
Hsu S.J.; PO-CHAO HUANG |
| 臺大學術典藏 |
2020-01-22T04:47:48Z |
High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments
|
Nien H.-C.;Hsu S.-J.;Su T.-H.;Yang P.-J.;Sheu J.-C.;Wang J.-T.;Lu-Ping Chow;Chen C.-L.;Kao J.-H.;Yang W.-S.; Nien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; LU-PING CHOW; Chen C.-L.; Kao J.-H.; Yang W.-S. |
| 國立成功大學 |
2020 |
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistan
|
Huang, C.-F.;Hung, C.-H.;Cheng, P.-N.;Bair, M.-J.;Huang, Y.-H.;Kao, J.-H.;Hsu, S.-J.;Lee, P.-L.;Chen, J.-J.;Chien, R.-N.;Peng, C.-Y.;Lin, C.-Y.;Hsieh, T.-Y.;Cheng, Cheng C.-H.;Dai, C.-Y.;Huang, J.-F.;Chuang, W.-L.;Yu, M.-L. |
| 臺大學術典藏 |
2019-11-27T02:02:26Z |
Development of interconnection materials for Bi2Te3 and PbTe thermoelectric module by using SLID technique
|
C. ROBERT KAO;Snyder G.J.;Kao C.R.;Ke J.H.;Yang H.W.;Zhu Z.X.;Liu C.K.;Dai M.J.;Liao L.L.;Lee C.C.;Hsu S.J.;Li C.C.; Li C.C.; Hsu S.J.; Lee C.C.; Liao L.L.; Dai M.J.; Liu C.K.; Zhu Z.X.; Yang H.W.; Ke J.H.; Kao C.R.; Snyder G.J.; C. ROBERT KAO |
| 臺大學術典藏 |
2019 |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H. |
| 國立成功大學 |
2019 |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu, M.-L.;Hung, C.-H.;Huang, Y.-H.;Peng, C.-Y.;Lin, C.-Y.;Cheng, P.-N.;Chien, R.-N.;Hsu, S.-J.;Liu, C.-H.;Huang, C.-F.;Su, C.-W.;Huang, J.-F.;Liu, C.-J.;Kao, J.-H.;Chuang, W.-L.;Chen, P.-J.;Chen, D.-S. |
